In conclusion, performing the combined detection of DCE-MRI and serum tumor markers (HE4, Ki67, and HK10) to OC patients can effectively improve the diagnostic accuracy rate and has higher sensitivity and specificity, which provides a new diagnostic assay in clinic and promotes the continuous progression of clinical diagnostic in a comprehensive and systematic manner. The gene discussed is WFDC2; the disease is neoplasm.